Guizhou Bailing Group Pharmaceutical Co., Ltd. — Investor Relations & Filings

Guizhou Bailing Group Pharmaceutical Co., Ltd. focuses on the research, development, production, and distribution of pharmaceutical products, with a specialized emphasis on Traditional Chinese Medicine (TCM) and ethnic Miao medicines. The company’s product portfolio covers a wide range of therapeutic areas, including respiratory health, cardiovascular diseases, and diabetes management. Notable products include cough syrups, capsules for cardiovascular health, and treatments derived from indigenous botanical sources. Guizhou Bailing integrates modern pharmaceutical technology with traditional herbal knowledge to develop standardized treatments. The company operates large-scale manufacturing bases and maintains a robust research and development infrastructure dedicated to clinical trials and the modernization of ethnic medicine. Its strategic focus involves the industrialization of traditional formulas to address chronic health conditions through evidence-based herbal pharmacology.